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Background: Feature selection (FS) process is essential in the medical area as it reduces the effort and time
needed for physicians to measure unnecessary features. Choosing useful variables is a difficult task with the
presence of censoring which is the unique characteristic in survival analysis. Most survival FS methods depend on
Cox’s proportional hazard model; however, machine learning techniques (MLT) are preferred but not commonly
used due to censoring. Techniques that have been proposed to adopt MLT to perform FS with survival data cannot
be used with the high level of censoring. The researcher’s previous publications proposed a technique to deal with
the high level of censoring. It also used existing FS techniques to reduce dataset dimension. However, in this paper
a new FS technique was proposed and combined with feature transformation and the proposed uncensoring
approaches to select a reduced set of features and produce a stable predictive model.
Methods: In this paper, a FS technique based on artificial neural network (ANN) MLT is proposed to deal with
highly censored Endovascular Aortic Repair (EVAR). Survival data EVAR datasets were collected during 2004 to 2010
from two vascular centers in order to produce a final stable model. They contain almost 91% of censored patients.
The proposed approach used a wrapper FS method with ANN to select a reduced subset of features that predict
the risk of EVAR re-intervention after 5 years to patients from two different centers located in the United Kingdom,
to allow it to be potentially applied to cross-centers predictions. The proposed model is compared with the two
popular FS techniques; Akaike and Bayesian information criteria (AIC, BIC) that are used with Cox’s model.
Results: The final model outperforms other methods in distinguishing the high and low risk groups; as they both
have concordance index and estimated AUC better than the Cox’s model based on AIC, BIC, Lasso, and SCAD
approaches. These models have p-values lower than 0.05, meaning that patients with different risk groups can be
separated significantly and those who would need re-intervention can be correctly predicted.
Conclusion: The proposed approach will save time and effort made by physicians to collect unnecessary variables.
The final reduced model was able to predict the long-term risk of aortic complications after EVAR. This predictive
model can help clinicians decide patients’ future observation plan.
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Endovascular aortic aneurysm repair (EVAR) is a surgical
operation for patients suffering from aorta inflation
known as aorta aneurysm. EVAR carries significantly
lower preoperative risk than open repair surgery; there-
fore, it is preferred by patients and recommended by med-
ical guidelines as the choice for treating abdominal aortic
aneurysm AAA [1]. There is an obligatory need for life-
long surveillance after this operation and it is considered
to be expensive, varied, and poorly-calibrated [2]. How-
ever, the surveillance procedures are extensively various
[3] and there is shortage of an indication to select the best
timing or modality; Patients may be exposed to radiations
and contrast nephropathy as a result of frequent surveil-
lance. However, for some patients, complications required
for treatment might be missed between surveillance [4–6].
For that reason, optimizing surveillance is very important
[7, 8]. It is considered as an important issue in clinics and
affects the long-standing cost-effectiveness of EVAR. By
specifying which patients are more (high risk patients) or
less likely (low risk patients) to require re-intervention
within 5 years, a cost-effective and risk-stratified surveil-
lance system could be achieved.
This study focuses on developing and validating a re-
duced predictive model for aortic complications after
EVAR. In previous literature, models were usually built
using only one dataset and validated with cross validation
method [9–12]. However, cross-center testing is essential
when the target is to validate the model for wider applica-
tions. Therefore in this work, two EVAR datasets were
collected in two vascular centers in the United Kingdom
which contain almost 91% of censored patients and which
make the survival model construction and classification of
difficult tasks. Censoring occurs when some patients could
not be observed in the whole period of the survival study
due to various reasons such as death, feeling better, or
changing their residence location, leading to a type of
missing data called censored data. The only information
available for censored patients is the time until the last fol-
low up or death (if it is not the event of interest). There-
fore, the time until the event of interest is unknown [13].
The task here is to construct a predictive model using
Center 1 EVAR data and testing it using other data col-
lected from Center 2 with the presence of this high level
of censoring. To deal with censoring, survival analysis
techniques are adopted. It enables the use of the informa-
tion available in the dataset even if it is censored. Actually,
it does not omit censored patients [13]. Survival analysis
techniques [14–16] were proposed with comparable data-
sets sizes to handle censoring.
Feature selection (FS) is very useful, especially in the
medical area, as it reduces the time needed and the effort
made by physicians to measure irrelevant and redundant
features. It could avoid over-fitting that might occurduring the learning process of the predictive model. It
may also lower the model’s complexity and speed up the
prediction process [17]. There are four primary ap-
proaches including filter, wrapper, embedded, and hybrid
methods in FS [18]. These methods are used widely for
standard data, though the task becomes more complex for
survival data due the presence of censoring [17]. There-
fore, the contribution of this paper is to select suitable fea-
ture selection methods for censored data, especially of a
high level, which exist in the EVAR datasets. In FS using
censored survival data, the most common approach used
for modeling censored data is Cox’s proportional hazard
model. Cox’s method uses the features information that
might affect the hazard to build a predictive model [19].
Popular methods that perform FS using Cox’s include;
wrapper FS methods which wrapped FS around Cox’s
model and used several criteria such as Akaike or Bayesian
information criteria, hazard ratio, and concordance index
calculated from its prediction [20–23]. Some used Cox’s
model as a filter approach and perform a univariate ana-
lysis to calculate Cox’s score metric for selection [24–28],
while others used Wald test or likelihood test criteria in-
stead [29] to quantify variables association with survival
prediction. Several other metrics such as chi squared test
[30], mutual information [31], and correlation information
[32, 33] were also used to rank or filter variables. Other
used penalized methods based on Cox’s model such as;
penalized L1 Least absolute shrinkage and selection oper-
ator (LASSO) [34, 35–38]. It was then extended to
adaptive LASSO, weighted LASSO, and gradient LASSO
[39, 40–42]. However, Lasso was used with another sur-
vival model called accelerated failure time model instead
of Cox [43] for constructing a survival model. Other pe-
nalized methods which perform feature selection include;
elastic-net [44, 45] and smoothly absolute clipped devi-
ation (SCAD) [46] models.
Machine learning techniques [20] (MLT), such as Bayes-
ian networks and Artificial Neural Networks (ANN), are
usually favorable over the standard statistical models such
as Cox due to their ability to identify complex relations
between data that improve prediction [47]. However, they
cannot be used directly on survival data due to the pres-
ence of censoring. Therefore, several scenarios have been
proposed to handle censoring, but these methods were
not applied to perform FS [48].
Some papers have discussed the use of MLT to perform
FS in survival analysis data with the presence of censoring.
Among them are the popular partial logistic artificial neural
network (PLANN) and its extension PLANN with auto-
matic relevance detection (PLANN-ARD). PLANN was
used with backward feature elimination [49]. PLANN-ARD
[11] method selects features based on their relevance to the
model according to a Bayesian framework. These methods
handle censoring by dividing observation time into n
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ing leads to unbalanced and biased predictive models, espe-
cially with high censoring level [50]. It also increases the
complexity and training time of these models and may in-
crease the noise level existing in the datasets. Authors in
[28] applied Cox’s model to perform FS on censored data
before entering a support vector machine (SVM) classifier.
Others used wrapper FS methods [51, 52] with Bayes classi-
fiers and K-nearest classifier. While in [30], a chi-square test
was used to measure the degree of association between var-
iables and observation time, then use ANN for prediction.
Random survival forest classifier [53] is an extension to
standard random forest classifier in which the output is sur-
vival time with a censor. It was used in [16, 54, 55] to per-
form FS. Gradient boosting with component-wise least
squares was proposed by [56] based on cubic smoothing
splines for L2 loss functions. It was then extended in [57]
which illustrated that boosting technique works well in
high-dimensional datasets for censored outcome data. Gra-
dient boosting was used in [58] for survival analysis, how-
ever it differs from [57] in the choice of loss function,
which in both cases is optimized via gradient boosting. The
limitation of methods [11, 28, 30, 49–52] is the way they
handled censoring which is carried out by deleting, ignor-
ing, using only uncensored patients, or considering cen-
sored patients as event free. These methods of handling
censoring are not appropriate to deal with a high level of
censoring which exists in the suggested EVAR datasets.
Moreover, the main drawback of tree based methods are in-
stability, variable selection bias and over-fitting [59].
In the researcher’s previously published paper [60], an
uncensoring approach was proposed to deal with the high
level of censoring in the EVAR datasets using MLT without
performing FS. Moreover, in the researcher’s other publica-
tion [61], the proposed uncensoring approach was com-
bined with an existing ranking FS method to reduce the
number of features in the datasets. Factor analysis is a fea-
ture transformation method used to transform data into a
new domain so that most of the classification related infor-
mation is compressed in a smaller number of features [62].
In this paper, it was used to group variables and to remove
variables that are not related to any group, rather than to
transform data into a new compressed domain used for
classification. Moreover, a new FS technique was proposed
to be combined with factor analysis and the researcher’s
uncensoring approach to select a reduced set of features
and produce a stable predictive model. A stable model
means that there may be a slight or no change in the pre-
diction error when the data examples used for its training
are replaced by other cases [63]. Prediction error is decom-
posed into two types; errors due to variance and or to bias.
In order to produce a stable algorithm, a tradeoff between
variance and bias must be made [64]. Therefore, the new
proposed FS approach addresses the instability issue toreduce bias and instability, which may be produced during
FS and improves consistency of the feature selection using
iterated nested cross validation method.
The proposed approach is divided into seven steps.
The first step is feature reduction using factor analysis
technique. The second is cross validation and permuta-
tion. The third is a stepwise feature selection which uses
the p-value of the log rank test as a criterion. The fourth
is the uncensoring step. The fifth is the iterated nested
cross validation step followed by the sixth ANN model
construction step. Steps two to six are repeated for each
fold produced from the cross validation and permuta-
tion. They are repeated until a model with the minimum
number of features is produced. The last step is the final
model selection step done to choose among the different
models constructed using each training fold generated in
the cross validation step. The final model is the one
which minimizes the p-value of the log rank test of the
remaining censored test fold that was not used in
training.
Methods
Data acquisition
From 2004 till 2010, follow up observations were collected
to patients experiencing EVAR surgery from two different
vascular centers located in the UK, at St George hospital
(Center 1) and Leicester (Center 2). Both datasets consist of
details of operative procedure and 47 patient morphological
features. Three-dimensional computed tomography (CT)
was employed to measure the pre-operational morphology
features. The slice thickness of the CT images was 0.625 or
1.25 mm. They were obtained from the thoracic inlet to the
level of the common femoral artery bifurcation. The total
numbers of patients after removing missing values are 457
and 286 respectively, and the number of patients that expe-
rienced the EVAR re-intervention during the study period
is 40 and 26 respectively for Centers 1 and 2. Details of
these datasets can be found in a previous publication [65].
Kaplan Meier curves
It is also known as product limit estimate of the survival
function. It is one of the most well-known non-parametric
survival analysis techniques. Non-parametric means that
it does not take into account the information available by
the predictive variables of a dataset when estimating sur-
vivability and does not assume survival distribution [66].
It calculates the probability of patient’s survival at any time
for the whole dataset even if it is censored. Clinical trials
adopt survival analysis techniques for several purposes,
such as predicting survivability after treatment of a dis-
ease, recurrent of cancer, or the risk of re-intervention
after a surgical intervention [67]. Kaplan Meier curves of
Centers 1 and 2 are plotted before using any feature selec-
tion method. They are shown in Fig. 1a and b.
ab
Fig. 1 Kaplan Meier curve for a center 1 EVAR data b center 2
EVAR data
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Factor analysis vs. principal component analysis
Principal Component Analysis (PCA) and Factor Ana-
lysis (FA) are the most well-known feature transform-
ation and reduction techniques. PCA produces new
features called components, which are the linear combi-
nations of the original ones. These components are or-
thogonal to each other. They represent the variance in
the data. Usually the first few components are the most
important. However, FA seeks to determine the under-
lying structure among variables, which cannot be dir-
ectly observed. It assumes that the attributes of data are
produced by a linear combination of unobserved ones
called latent factors. There are two types of factors, com-
mon and unique. The common factor is an unobserved
variable that expresses the common variance between
two or more observed variables (original measuredvariables). The unique variance is an unobserved variable
that explains the variance of only one observed variable.
Features that are not correlated to any factor may be
considered as unimportant and may be removed from
the data. Therefore, FA is favorable than PCA as it aims
to find the minimum number of factors that explain the
underlying structure of the data [68]. Additionally, PCA
does not take into account the effect of unique variance
in determining principal components; it only regards the
common variance. FA considers both the common and
unique variances in calculating latent factors.
Factor rotation
FA seeks to reduce the dimension of data in order to
visualize and understand grouping and underlying struc-
tures between variables. Though, sometimes the primary
latent factors are not able to clearly demonstrate this.
Therefore, factor rotation may be needed to solve the
problem. Rotation process is applied to the primary fac-
tors by rotating them into new axes called rotated fac-
tors [69]. These new axes produce large loading factors
on one or two of the rotated factors, and small loading
factors on others. The varimax and promax rotations are
the most popular rotation techniques. A varimax rota-
tion creates orthogonal uncorrelated rotated factors,
while promax produces oblique ones [70]. In some cases,
a promax rotation is favorable over varimax as it is a fas-
ter and simpler method [71]. However, in this paper
varimax rotation was used to generate uncorrelated ro-
tated latent factor in order that the variable related to
different latent factors will be uncorrelated.
Cox proportional hazard model
Cox-proportional hazard or Cox regression is the most
popular semi-parametric method used in clinical trials. It
builds a hazard model using covariates values by assuming
that their effect on survival function is constant over time
[72]. The relationship between patients’ survival and co-
variates are investigated using Cox’s model. In other
words, it is used to estimate the risk of event given the
prognostic variables at a time t. The model’s output will
be a hazard as a function of time and specific covariates.
Bayesian networks
Bayesian network follows a particular structure of prob-
abilistic graphical models known as directed acyclic graph
(DAG). A DAG consists of a number of nodes (vertices)
V = {V1,V2,V3, .…Vn} representing variables and arcs
A V ×Vconnecting them and representing conditional
and unconditional dependencies between these variables.
Each node V represents a specific random variable and is
drawn as a circle with its name on it. Arcs connecting the
nodes are drawn as arrows and must be directed in only
one direction which means that when an arc leaves a
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be considered as a parent node when an arrow comes out
of it. It can also be a child node when an arrow points to-
wards it. BN illustrates relations and joint probabilities
among variables of a dataset. This interpretability and its
ability to provide reasoning with uncertainty make it ap-
propriate to be used in the proposed approach.
Artificial neural network
Artificial neural networks (ANNs) is one of the most
popular and widely used ML techniques, especially in
the medical area, as it has high ability to get good pre-
diction even with noisy data [74] like the endovascular
aortic repair (EVAR) datasets used in this paper. The
artificial neural networks (ANN) are models stimulated
by the biological nervous system of animals and specific-
ally the neural networks of the brain [75]. Multilayer
perception MLP-ANN is the commonly used ANN in
the medical area. It consists of a number of neurons re-
ferred as nodes connected together by weights. These
nodes are gathered together to form N layers consisting
of one input, one output, and one or more hidden layers.
The learning process in ANN is done by changing the
weights of the connected neurons with the help of the
training data and a learning algorithm.
The proposed algorithm
The proposed technique used Center 1 (457 patients)
for feature selection and Center 2 (286 patients) for its
validation and assessment.
The proposed algorithm is divided into seven main
steps. The flowchart in Fig. 2 describes the subsequent
procedures. It also illustrates the main three areas of
contributions of the proposed approach which are fea-
ture selection, uncensoring, and classification with their
interactions which are highlighted in blue. Step 1 is re-
ducing features using factor analysis. It applies factor
analysis technique in order to lower the dimension of
the data as an initial step. This was done after using
Kaiser-Meyer-Olkin and Bartlett’s tests to examine
whether FA is needed for the data [76, 77]. Step 2 is the
cross validation which splits Center 1 data into five
outer training and testing folds and this is called the
outer loop. It is used in the feature selection process for
choosing the final reduced model, which produces the
smallest p-value of the log rank test. Step 3 is the feature
selection process which uses the p-value of the log rank
test to select the variables used to build the ANN model
from the uncensored training folds of Center 1 data.
Step 4 is the uncensoring of the EVAR data. Step 5 is
the iterated nested cross validation; which re-splits each
outer training fold into five inner (nested) training and
testing partitions. This is called the inner loop and it
was used to overcome overoptimistic prediction thatmay occur during feature selection, uncensoring and
ANN construction steps. Moreover, this process pro-
duces a stable algorithm that tunes the tradeoff between
variance and bias [78, 79]. Step 6 is the ANN model
construction used for predicting the risk of re-
intervention. Step 7 is to select the final model with the
optimal number of features; the chosen model is the one
which minimizes the p-value of the log rank test on the
remaining testing fold which has not been used in the
FS and ANN construction process. This p-value is used
to determine whether the ANN model built with the se-
lected features was capable of differentiating between
the two risk groups of the censored Center 2 EVAR data.
Usually, when it is lower than a significance level of
0.05, the two risk groups are considerably different, dis-
criminative and separable. In the following subsection,
each step will be discussed in detail.
Feature reduction using factor analysis step
FA was employed in this work as a first step to reduce the
dimension of the datasets by eliminating the variables that
are not related to any latent factor. This will reduce the
computational cost required later in the proposed feature
selection algorithm. The number of latent factors has to
be determined first in order to start FA. In order to deter-
mine the number of latent factors used in factor analysis,
a scree plot is produced which shows the Eigen values ac-
companied with principle components or latent factor
listed in descending order versus the number of compo-
nents or factors as shown in Fig. 3, only 6 components
showed almost 80% of the variance in the data. Therefore,
the number 6 is adopted to do FA on Center 1 data.
After applying FA on the data, insignificant variables
should be removed from the dataset. The most common
criterion used to drop these variables is communality which
is the part of the variance generated from the common fac-
tors. It is calculated by summing the squared factor load-
ings of all common factors for a given variable [80]. Factor
loadings are the values or weights (called loadings) multi-
plied by each factor, then added together to form a linear
combination of factors that produce observed variables. As
a rule of thumb, when a variable has large loadings to some
factors, this means that this variable can be represented by
particular factors. Therefore, it should be retained as it is
considered an influential observed variable [81]. For this
reason, communality of high values is better. If the commu-
nality of a variable is high, this means that the factors de-
scribe a large percentage of the variable’s variance. Hence,
this indicates that this specific variable is well explained by
the common factors, and therefore that the factor analysis
is reliable. Low communality of a variable indicates that this
variable does not load to any factor (have low loading fac-
tors), can be removed, and is considered a non-influential
variable [81, 82]. Communality equals to (1- uniqueness).
Fig. 2 Flow chart of the proposed algorithm
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Fig. 3 Scree Plot of the PCA using Center1 EVAR data
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the variance produced due to unique factors. In this work,
the threshold of communality according to which features
are dropped is determined from the histogram of unique
variances (uniqueness), produced by unique factors. Vari-
ables with uniqueness values greater than this threshold will
be removed, as they correspond to low communalities. As
shown in Fig. 4, the first sudden drop in the uniquenessFig. 4 Histogram of the Uniqueness values for center1 EVAR at attributesoccurs at 0.25. The researcher has chosen this threshold as
other greater values correspond to high uniquenesses and
low communalities.
Cross validation and permutation step
Center 1 EVAR data is divided into five folds using
five folds cross validation method. Each separate four
folds are called the outer training fold and the fifth is
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is used in nested cross validation, stepwise feature se-
lection, uncensoring, and ANN construction steps
later. During the stepwise feature selection step, it is
permuted five times to produce its replicas after being
uncensored (in the uncensoring step).
Stepwise feature selection step
In the stepwise feature selection (SWFS) step, a ca-
nonical greedy stepwise search was used to select fea-
tures using the p-value of the log-rank test as a
performance metric. It is divided into two stages; fea-
ture elimination and addition. The main advantage of
this strategy is that the eliminated features are given
another chance to re-enter the feature selection
process. It starts with the elimination stage in which
all the features of each outer training fold is elimi-
nated iteratively and the rest are used in the uncen-
soring and ANN construction steps after being
permuted and re-split into inner nested folds to cal-
culate the average of the p-value of the log-rank test.
This prevents over-fitting and overoptimistic p-value
predictions and enables the production of a stable
model. The subset with the smallest averaged p-value
is the one chosen and called “minimum subset” and
its average p-value is called the “minimum averaged
p-value”. Features eliminated will be inserted in a
subset called the “visited subset” and will be given an-
other chance to enter the FS process again in the
addition stage. This is done by adding features of the
visited subset iteratively, and then repeating the
uncensoring and ANN construction steps. If the sub-
set with the smallest average p-value has a p-value
lower than the “minimum averaged p-value”, then this
subset is set as the “minimum subset” and its p-value
as the new “minimum averaged p-value”. This proced-
ure is repeated until all features are visited.
Uncensoring step
The censoring time variable for each outer training
loop was used to divide patients into three groups.
The first one belongs to patients that experience the
re-intervention at a time shorter than or equal to
5 years (re-intervened or high risk patients). The sec-
ond group refers to patients that did not need the re-
intervention for longer than 5 years (low chance of
re-intervention or low risk patients). Finally, the rest
of the patients are considered as the censored group
which is the third group (those who died or left the
follow up observations before 5 years).
Afterwards, each outer training fold was discretized
using equal width unsupervised discretization technique.
Then, each risk group was employed to build two Bayes-
ian networks called low and high risk networks Blow andBhigh, respectively. Each Bayesian network is a directed
acyclic graph (DAG) given a symbol ξ. They are con-
structed using the input variables V. Each variable Vi
represents a node in this network and its parent is de-
fined by π. The Bayesian networks were learned with Hill
climbing structure learning algorithm [83]. The scoring
function used for choosing the structure of the network
has a minimum description [84]. Parameter learning was
done using a maximum likelihood procedure to determine
relation between nodes of a network [85].
The output class of each risk group is then removed as
it is already known in the network. Next, each censored
patient from the censored group is compared with the
intrinsic distribution p of each network phigh and plow, cor-
respondingly. Likelihood ℓ(xc/p) of the censored patients
belongs to which network is used to uncensor the patient
and determine to which group he/she belongs. It is calcu-
lated using Eqs. (1) and (2)
ℓ̂ xc=p
high
  ¼ ℓ xc=Bhigh
  ¼ p xc=ξhigh; phigh
 
¼
Yn
i¼1
phigh V i=π V ið Þð Þ: ð1Þ
ℓ̂ xc=p
low
  ¼ ℓ xc=Blow
  ¼ p xc=ξ low; plow
 
¼
Yn
i¼1
plow V i=π V ið Þð Þ: ð2Þ
Afterwards, the posterior probability that outcome pre-
dictions that patients belong to each network given that
they are censored (xc) P(O/xc) in Eq. (5) is calculated using
Eqs. (3) and (4).
P Ohigh=xc
  ¼ P^ Ohigh  ℓ
̂ xc=phigh
 
P xcð Þ : ð3Þ
P Olow=xc
  ¼ P^ Olow  ℓ
̂ xc=plow
 
P xcð Þ : ð4Þ
P O=xcð Þ ¼ P Ohigh=xc
 þ P Ohigh=xc
 
¼ P^ O
high
   ℓ^ xc=phigh
 þ P^ Olow   ℓ^ xc=plow
 
P xcð Þ ;
ð5Þ
Equation (5) is then normalized to ignore the effect of
probability of a censored instance P(xc) by dividing Eq.
(5) by P(O/xc)*P(xc) to get Eq. (6).
P Ohigh=xc
 þ P Olow=xc
  ¼ 1: ð6Þ
Finally, a threshold named censoring correction PTh is
selected to determine whether each censored patient be-
longs to the high or low risk groups. If P(Ohigh/xc) is big-
ger than PTh, the censored patient will be considered as
high risk and vice versa.
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After uncensoring all the replicas of each outer train-
ing partition, each replica is divided into five nested
folds. Every different four folds are called inner train-
ing folds and are used to build an ANN (in the ANN
construction step), while the fifth one is called inner
test fold and is used for measuring the performance of
the ANN using the p-value of the log-rank test of this
inner test set. This is done for the different inner
training and testing folds. Afterwards, the average of
the p-value is then calculated. This process prevents
overoptimistic results. It is worthy of note that each
outer training fold was used to construct the ANN
with different number of neurons. The process is re-
peated for every replica of the outer training fold, and
then the average of all of them is calculated to pro-
duce the p-value of the nested cross validation which
is used in the stepwise feature selection step as a cri-
terion to select the attributes. It produces a stable
model that tunes the tradeoff between variance and
bias. Nested cross validation is also used as a method
of avoiding over-fitting used due to the small sample
size available in the data.ANN construction step
A three layer MLP-ANN trained with gradient descent
with momentum back propagation algorithm was used
to build a model for every outer training fold with differ-
ent number of neurons. Sigmoid was used as an activa-
tion function. Other parameters are kept with their
default values. Each model was used in the feature selec-
tion process to determine which one has the optimal
features that minimize the p-value. The model has the
ability to distinguish between the two risks groups of
Center 1 data used in the ANN construction and can be
validated with Center 2 data. The k-fold cross validation
procedure was used to select the number of hidden neu-
rons that reduces chances of over-fitting. In addition, it
was employed and combined with feature selection and
iterated nested cross validation to reduce chances of
over-fitting.Table 1 Results of the proposed algorithm with the real dataset
The proposed
algorithm
Number of
features
p-value
(Logrank)
CI(standard
error SE)
Sensitivity
All Features 45 0.036 0.6 (0.0677) 0.46
FA Features 27 0.034 0.61(0.0715) 0.57
Stepwise
selection Features
7 0.022 0.63 (0.0739) 0.73Final model selection step
Finally, five models will be produced from the five outer
training folds that were used to build an ANN with dif-
ferent numbers of neurons. Each one is tested with the
outer test fold which is not used in the ANN construc-
tion and the feature selection steps. The model that pro-
duces the minimum p-value in the outer test fold is the
one chosen as a final model. The number of features
and neurons produced in this model is used to train an
ANN using Center 1 data. Center 2 data is used to valid-
ate the selected model.Results
Results of the proposed feature selection method
One common approach for feature selection is to utilize
the whole data set for the selection procedure. Re-
sampling techniques such as cross validation and boot-
strapping can split data into separate parts. Parts will be
used for feature selection and evaluation. The other part
that is not used in model construction will be used for
validation and assessing the performance of the final fea-
ture selected model. In the proposed algorithm, Center
1 data were used for the feature and model selection
(number of hidden neurons of ANN), while Center 2
data were employed for the validation and assessment.
Cross and nested cross validation re-sampling tech-
niques were used to split Center 1 data. The inner
nested loop was used for producing an unbiased, stable
algorithm and overcoming over-fitting and the overopti-
mistic predictions that might be produced. The outer
loop was used to choose the model that produces the
smallest p-value of the log-rank test on the outer test
set. It is worth mentioning that the ANN of final chosen
model has the number of neurons equal to seven.
Table 1 shows the results of using all the features avail-
able in Center 1 data and the results after FA reduction
and the stepwise FS steps. It is clear from Table 1 that the
number of features has been reduced from 45 to 27 after
the FA step. The CI for Center 2 prediction has increased
from 0.6 to 0.61. The p-value for Center 2 has improved
from 0.036 to 0.034. It is also obvious from the table that
the number of features selected in the final model after
the stepwise selection step is lowered to 7. The p-value
and CI for Center 2 predictions have improved to 0.022
and 0.63, respectively.
Results of the final model of the proposed method
compared to Cox’s models based on AIC, BIC, lasso, and
SCAD
In this section, the results of the final model produced by
the proposed algorithm are compared with the most well-
known, semi-parametric method used in clinical trials,
Cox’s Hazard proportional model. AIC, BIC, Lasso, and
SCAD are popular feature and model selection techniques
that are used with Cox’s model to produce a stable algo-
rithm with reduced number of features. It is well known
that the Cox’s output is continuous. In order to convert
this output to binary outcome indicating the risk group,
Table 3 Results of center2 data using the proposed algorithm
compared with Cox’s model using AIC, BIC, Lasso, and SCAD
Algorithm
used
Number of
features
p-value
(Logrank)
CI(SE) Uno’s
AUC
Sensitivity
Proposed
Algorithm
7 0.022 0.63 (0.0739) 0.612 0.73
AIC
Algorithm
14 0.034 0.61 (0.0725) 0.60 0.35
BIC
Algorithm
14 0.029 0.63 (0.0685) 0.605 0.23
Lasso
Algorithm
7 0.0068 0.615 (0.0864) 0.627 0.5
SCAD
Algorithm
3 0.2759 0.592 (0.0658) 0.58 0.6923
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plied by each variable to generate a risk score and a
threshold value is used to separate risk groups. A value
above the threshold indicates high risk (class value of 1)
and vice versa. The threshold that separated the two risk
groups for Center 1 was 3.1 using AIC which is equivalent
to the mean value of the risk score. The thresholds for
BIC, Lasso, and SCAD are 2.4, 6.3, and 1.8, respectively.
The same threshold is applied to Center 2 data. Tables 2
and 3 show the results of the proposed algorithm com-
pared with the results of AIC, BIC, Lasso, and SCAD for
Centers 1 and 2, respectively. The hyper parameter of
Lasso and SCAD methods was optimized using ten-fold,
cross validation.
It is obvious from Table 2 that the proposed algorithm,
AIC, BIC, Lasso, and SCAD Cox’s algorithm have all suc-
cessfully distinguished the two risk groups of Center 1 as
they all have p-value lower than 0.00001 except for SCAD
which has a p-value of 0.0078. These p-values are beyond
the significant level 0.05. The CI of AIC, BIC, Lasso,
SCAD Cox’s models are 0.79, 0.76, 0.7382, and 0.6271,
which are greater than the proposed algorithm 0.74 except
for the SCAD (0.6271). However, the proposed algorithm
outperforms the AIC and Cox algorithm in the number of
features selected in the final model which is 7, while in the
other two methods it is 14. The proposed algorithm has
the same number of selected features as Lasso [7], but
greater than SCAD [3]. The advantage of using the pro-
posed algorithm over the other methods in predicting the
risk of re-intervention appears clearly in the predictions of
Center 2 as shown in Table 3. First, it has the same CI
0.63 as the BIC model and outperforms the AIC, Lasso,
and SCAD with CI equals to 0.61, 0.615, and 0.592. More-
over, it has an AUC (0.612) which is better than that of
AIC, BIC, and SCAD (0.6, 0.605, and 0.58, respectively).
However, the AUC of the proposed method is lower than
that of Lasso 0.627. Finally, the p-values of the proposed
method, AIC, BIC, Lasso, and SCAD algorithms are 0.022,
0.034, 0.029, 0.0068, and 0.2759. These p-values indicate
that the results of all models can be separated significantly
to distinguish between the high and low risk groupsTable 2 Results of center1 data using the proposed algorithm
compared with Cox’s model using AIC, BIC, Lasso, and SCAD
Algorithm
used
Number of
features
p-value
(Logrank)
CI(SE) Sensitivity
Proposed
Algorithm
7 <0.00001 0.74 (0.0439) 0.76
AIC Algorithm 14 <0.00001 0.79 (0.0408) 0.69
BIC Algorithm 14 <0.00001 0.76 (0.0465) 0.38
Lasso
Algorithm
7 <0.00001 0.7382 (0.0426) 0.714
SCAD
Algorithm
3 0.0078 0.6271 (0.0518) 0.643except for SCAD which has p-value of 0.2759 which is
greater than 0.05.
Figure 5 shows the KM curves of the two risk groups
using the final selected model of the proposed algorithm
for Center 1 compared with AIC (Fig. 6), BIC (Fig. 7), Lasso
(Fig. 8), and SCAD (Fig. 9), respectively. Figure 10 shows
the KM curves of the two risk groups using the final se-
lected model of the proposed algorithm for Center 2 com-
pared with AIC (Fig. 11), BIC (Fig. 12), Lasso (Fig. 13), and
SCAD (Fig. 14), correspondingly. Moreover, these figures
include the probability of freedom from aortic complica-
tions within the 5 years after EVAR along with the number
of patients at risk of each group (low and high risks).
Figure 5 also shows that the proposed algorithm classi-
fied 169 of the Center 1 patients as high risk, which is
equivalent to 37% of the patients. Freedom from aortic
complications of the high risk patients reached 58.7% vs.
94.4% in low risk patients in the fifth year as shown in
Fig. 5 (p < 0.00001 log-rank test). However, the AIC,
BIC, Lasso, and SCAD Cox’s model predicted 104, 58,
196, and 208 patients as high risk as shown in Figs. 6, 7, 8
and 9. These are equivalent to 23, 13, 42, and 45.5% of the
patients. Freedom from aortic complications of the high
risk patients reached using AIC, BIC, and Lasso are 52%
vs. 93%, 57.6% vs. 87.4%, and 91.7% vs. 73% in low risk pa-
tients in the fifth year (p < 0.00001 log-rank test). For,
SCAD, the high risk is 79.2% vs. 97.5% of the low risk in
the fifth year (p = 0.0078 log-rank test).
Figure 10 shows that the proposed algorithm classified
136 of the Center 2 patients as high risk, which is
equivalent to 47.5% of the patients. Freedom from aortic
complications of the high risk patients reached 69% vs.
92.6% in low risk patients in the fifth year (p < 0.022
log-rank test). However, the AIC, and BIC Cox’s model
predicted 25 and 41 patients as high risk as shown in
Figs. 11 and 12, which is equivalent to 8 and 14.3% of
the patients. Freedom from aortic complications of the
high risk patients reached 39.5% vs. 83% and 53.7% vs.
84.6% in low risk patients in the fifth year (p = 0.034
Fig. 5 Kaplan Meier curves of the risk groups of center 1 prediction using the proposed algorithm
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predicted 76 and 121 patients as high risk as shown
in Figs. 13 and 14, which is equivalent to 26.5 and
42.3% of the patients. Freedom from aortic complica-
tions of the high risk patients reached 60.7% vs.
87.5% for low risk in Lasso and 72.5% vs. 89.2% in
low risk patients in SCAD in the fifth year (p = 0.034
and 0.029 log-rank test).
Discussion
The influence of aortic morphology on long term predic-
tion of EVAR is complicated and suitable to be analyzed
with ANN, with significant possible interface between aor-
tic volume, shape, diameter, and angulation. Current ap-
proaches have shown that aneurysm diameter predicts re-
intervention after EVAR [86, 87], however evidence also
recommended that other features of aneurysm morph-
ology influence long-term clinical success [88–90]. Fur-
ther complex concerns such as endograft configuration
and deployment, or intermediate markers of patients’ car-
diovascular risk phenotype, could possibly be used to train
ANN in prospective studies, which increases the clinical
significance of prediction and makes it more reliable. Also,
adding more operative factors such as graft size, and
endoleak at completion or post-operative variables, such
as endoleak at early surveillance scans, could significantlyenhance the discriminatory power of ANNs [61]. As an
evidence, the proposed FS approach using ANN has se-
lected maximum aneurysm neck diameter, diameter of the
left common iliac artery 1 and 5 mm below internal iliac
ostium, maximum common iliac artery diameter 5 mm
proximal to internal iliac origin, maximum iliac tortuosity
index, maximum common iliac thrombus volume, and
right common iliac artery non luminal volume. These fea-
tures were examined by clinicians who approved that
they have outstanding validation terms for the predic-
tion morphology for current endografts available. Re-
sults were compared with current clinical method
such as; SGVI (St George Vascular Institute), which
showed that the proposed method has superior per-
formance. The seven features ANN of the proposed
method have greater predictive ability in classifying
low and high risk patients than the SGVI score [91].
Concordance index, estimated AUC, and p-value of
the predictive model using the selected features show
good clinical sense. In addition, they potentially indi-
cate an increase in the event detection (EVAR re-
intervention in this study) and risk group separation
without affecting the cost of collecting unnecessary
additional variables and surveillance cost.
Details about the uncensoring algorithm, could be
found in [60]. Both Bayesian and neural network were
Fig. 6 Kaplan Meier curves of the risk groups of center 1 predictions using the AIC –Cox’s model
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is used in this paper as it helps physicians and clini-
cians to understand the relations between variables. It
is a graphical probabilistic network and it determines
the joint probabilities between the variables of a data-
set. Each variable is given as a node in the network.
The final graph makes it easier for doctors to figure
out the relations between the variables and how pre-
dictions are performed, as they are less aware of data
mining and machine learning techniques [31]. The
structures of the Bayesian networks generated after
feature selection can be found in Additional file 1.
This work has several contributions; the first one is
to use machine learning techniques such as Bayesian
networks and Artificial Neural networks to solve cen-
soring issue and build a predictive model. As men-
tioned before, previous techniques that used machine
learning techniques dealt with low to medium level
censoring. Moreover, the way they handled censoring
may lead to a biased predictive model, especially with
high censoring. The second one is to deal with the high
censoring issue which is a major difficulty in datasets
that prevent building a predictive model capable of pre-
dicting the risk of EVAR re-intervention. Since most of
the previous studies used only one dataset split using k-fold cross validation or bootstapping to validate the re-
sults. The third contribution is to justify the model in
future cross-center applications by constructing a pre-
dictive model using Center 1 EVAR data and testing
them using other data collected from Center 2. Earlier
work was mainly concerned with dealing with the
censoring issue without performing FS. Existing FS
methods dealing with censored data have several draw-
backs and cannot be used with the highly censored
EVAR datasets as mentioned before in the introduction.
The fourth one is to apply the appropriate feature se-
lection techniques to the highly censored endovascular
repair survival data.
The proposed algorithm used Bayesian network to
uncensor the highly censored EVAR datasets and ANN
for prediction of risks. It employed FA reduction and
stepwise FS to reduce the number of features used for
building the predictive model. It used cross validation
for model selection (choosing the number of neurons of
ANN) and iterated nested cross validation to generate a
stable feature selection algorithm and produce the final
reduced model. A simulation study was performed and
included in the Additional file 2 to show the effective-
ness of the proposed algorithm compared with other
variable selection methods.
Fig. 8 Kaplan Meier curves of the risk groups of center 1 predictions using the Lasso –Cox’s model
Fig. 7 Kaplan Meier curves of the risk groups of center 1 predictions using the BIC –Cox’s model
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Fig. 10 Kaplan Meier curves of the risk groups of center 2 predictions using the proposed algorithm
Fig. 9 Kaplan Meier curves of the risk groups of center 1 predictions using the SCAD –Cox’s model
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Fig. 12 Kaplan Meier curves of the risk groups of center 2 predictions using the BIC –Cox’s model
Fig. 11 Kaplan Meier curves of the risk groups of center 2 predictions using the AIC –Cox’s model
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Fig. 13 Kaplan Meier curves of the risk groups of center 2 predictions using the Lasso –Cox’s model
Fig. 14 Kaplan Meier curves of the risk groups of center 2 predictions using the SCAD –Cox’s model
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A new feature selection technique was proposed to build
and validate a predictive reduced model using the two
EVAR datasets (743 patients) collected during 2004 to
2010 from two vascular centers. The final reduced
model was able to predict the long-term risk of aortic
complications after EVAR. Only morphology features
were used for constructing the model as they have
greater effect on aortic complications than physiology
ones [6, 93, 94]. The proposed feature selection tech-
nique has successfully reduced the final model to 7 fea-
tures only instead of the full model of 45 attributes. The
final reduced model was validated using Center 2 data
and the results showed that it was capable of predicting
the risk of EVAR re-intervention. It was also able to suc-
cessfully distinguish between the two risk groups of each
center as the p-value of the log rank test was lower than
0.00001 for Center 1 and 0.022 for Center 2. This proves
that the model can be used in cross-center predictions.
This will help clinicians to put a future different follow
up surveillance plan for different risk groups of EVAR
patients.
Four other popular feature selection techniques AIC,
BIC, Lasso, and SCAD were compared to the proposed
algorithm. The reduced predictive model constructed
using the proposed approach has higher ability in dis-
criminating and distinguishing between risk groups of
patients than other variable selection methods based on
Cox’s model, since it has better concordance index, and
estimated AUC. In addition, the number of patients of
Center 1 that were classified as high risk using the pro-
posed method, AIC, BIC, Lasso, and SCAD Cox’s
models are 169, 104, 58, 196, and 208 patients versus
136, 25, 41, 76, and 121 for Center 2. This means that
the proposed algorithm better identifies the risk of
EVAR re-intervention. Therefore, it may be preferred by
doctors to decide which surveillance plan each patient
should undertake. Clinicians will put a more regular
monitoring schedule in the future follow up and surveil-
lance plan for those who have high risk of needing re-
intervention, and the lower risk patients can be moni-
tored less regularly. This would help in balancing and
developing a cost-effectiveness surveillance system.
Additional files
Additional file 1: The structures of the high and low bayesian networks
after feature selection. (PDF 208 kb)
Additional file 2: Comparative variable selection survival models and
the generated Simulation Study. (PDF 180 kb)
Abbreviations
AAA: Abdominal aortic aneurysm; AIC: Akaike information criteria;
ANN: Artificial neural network; BIC: Bayesian information criteria; BN: Bayesian
network; BP: Back propagation; CI: Concordance index; CT: Computedtomography; DAG: Direct acyclic graph; EVAR: Endovascular aortic repair;
FA: Factor analysis; FR: Feature ranking; FS: Feature selection; KM: Kaplan
Meier; Lasso: Least absolute shrinkage and selection operator; MLP: Multilayer
perceptions; MLT: Machine learning techniques; MPL: Maximum partial
likelihood; PCA: Principal component analysis; PH: Proportional hazard;
PLANN: Partial logistic regression artificial neural network; REINT: Risk of
endovascular aortic repair intervention; SCAD: Smoothly clipped absolute
deviation; SWFMS: Stepwise feature model selection
Acknowledgments
We would like to acknowledge Prof. David Lowe at Aston University for his
guidance and useful discussions on this research.
Funding
The authors have no support or funding to declare.
Availability of data and materials
The data cannot be made available outside of the English National Health
Service due to existing data agreements covering patients treated in the
authors’ healthcare system and local/national data governance policies. Data
are available upon request from the author Alan Karthikesalingam.
Authors’ contributions
All authors made substantial contributions to the algorithm design and
methods. OA implemented the methods, analyzed and interpreted the
data, prepared the draft of the paper. XM revised the manuscript
critically for important intellectual content and approved the final
version to be submitted. AK, PH, and MMT collected Center 1 dataset.
RS, MJB, EC collected Center 2 dataset. All authors read and approved
the final manuscript.
Ethics approval and consent to participate
The study (including anonymised imaging data from Leicester and St
George’s hospital patients) was classified as service evaluation by
communication with Wandsworth Research Ethics Committee REC in
2012, when the data analysis plan was conceived. Wandsworth REC
waived the need for approval as this was a retrospective observational
study of anonymised data.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1School of Engineering and Applied Science, Aston University, B4 7ET,
Birmingham, UK. 2Department of Electronics and Communications, College
of Engineering and Technology, Arab Academy for Science and Technology,
Alexandria, Egypt. 3St George’s Vascular Institute, London SW17 0QT, UK. 4St
George’s Vascular Institute, St George’s University Hospitals NHS Foundation
Trust, Blackshaw Road, London SW17 0QT, UK. 5Vascular Surgery Group,
University of Leicester, Leicester, UK. 6Vascular Surgery Group, Robert
Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, University of
Leicester, Leicester LE2 7LX, UK.
Received: 5 July 2016 Accepted: 24 July 2017
References
1. Moll FL, et al. Management of abdominal aortic aneurysms clinical practice
guidelines of the European society for vascular surgery. Eur J Vasc Endovasc
Surg. 2011;41:S1–S58.
2. Hay N, McCracken F, Richardson J, George E, Barnett D. Endovascular stent-
grafts for the treatment of abdominal aortic aneurysms: NICE technology
appraisal guidance. Heart. 2009;95:1798–800. doi:10.1136/hrt.2009.176362.
Attallah et al. BMC Medical Informatics and Decision Making  (2017) 17:115 Page 18 of 193. Karthikesalingam A, et al. Heterogeneity in surveillance after endovascular
aneurysm repair in the UK. Eur J Vasc Endovasc Surg. 2011;42:585–90.
doi:10.1016/j.ejvs.2011.06.053.
4. Weerakkody RA, et al. Radiation exposure during endovascular aneurysm
repair. Br J Surg. 2008;95:699–702. doi:10.1002/bjs.6229.
5. Walsh SR, Tang TY, Boyle JR. Renal consequences of endovascular
abdominal aortic aneurysm repair. J Endovasc Ther. 2008;15:73–82.
doi:10.1583/07-2299.1.
6. Karthikesalingam A, et al. Risk of reintervention after endovascular aortic
aneurysm repair. Br J Surg. 2010;97:657–63. doi:10.1002/bjs.6991.
7. Brown LC, et al. The UK EndoVascular aneurysm repair (EVAR) trials: design,
methodology and progress. Eur J Vasc Endovasc Surg. 2004;27:372–81.
doi:10.3310/hta16090.
8. Chambers D, Epstein D, Walker S, Fayter D, Paton F, Wright K, Michaels J,
Thomas S, Sculpher M, Woolacott N. Endovascular stents for abdominal
aortic aneurysms: a systematic review and economic model. Health Technol
Assess. 2009;13:215–318. doi:10.3310/hta13480.
9. Brown SF, Branford AJ, Moran W. On the use of artificial neural networks for
the analysis of survival data. IEEE Trans Neural Netw. 1997;8:1071–7.
doi:10.1109/72.623209.
10. Delen D, Walker G, Kadam A. Predicting breast cancer survivability: a
comparison of three data mining methods. Artif Intell Med. 2005;34:113–27.
11. Lisboa PJ, Wong H, Harris P, Swindell R. A Bayesian neural network
approach for modelling censored data with an application to prognosis
after surgery for breast cancer. Artif Intell Med. 2003;28:1–25.
12. Kalderstam J, et al. Training artificial neural networks directly on the
concordance index for censored data using genetic algorithms. Artif Intell
Med. 2013;58:125–32.
13. Singh R, Mukhopadhyay K. Survival analysis in clinical trials: basics and must
know areas. Perspect Clin Res. 2011;2:145–8. doi:10.4103/2229-3485.86872.
14. Neuberger J. Predicting the prognosis of primary biliary cirrhosis. Gut.
1989;30:1519–22.
15. Zhu M, Fan G. Variable selection by ensembles for the Cox model. J Stat
Comput Simul. 2011;81:1983–92.
16. Pang H, George SL, Hui K, Tong T. Gene selection using iterative feature
elimination random forests for survival outcomes. IEEE/ACM Trans Comput
Biol Bioinform. 2012;9:1422–31.
17. Liu H, Motoda H. Feature selection for knowledge discovery and data
mining, vol. 454: Springer Science & Business Media; 1998. http://www.
springer.com/gp/book/9780792381983.
18. Jain A, Zongker D. Feature selection: evaluation, application, and small
sample performance. IEEE Trans Pattern Anal Mach Intell.
1997;19:153–8.
19. Prinja S, Gupta N, Verma R. Censoring in clinical trials: review of survival
analysis techniques. Indian J Community Med. 2010;35(2):217–21.
doi:10.4103/0970-0218.66859.
20. Yu S-L, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ,
Lee YC, Chen HS. MicroRNA signature predicts survival and relapse in lung
cancer. Cancer Cell. 2008;13:48–57.
21. Choi I, Wells BJ, Yu C, Kattan MW. An empirical approach to model selection
through validation for censored survival data. J Biomed Inform. 2011;44:
595–606.
22. Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ,
Ruether JD, Cheng T, North S. Prognostic factors for overall survival in
patients with metastatic renal cell carcinoma treated with vascular
endothelial growth factor–targeted agents: results from a large, multicenter
study. J Clin Oncol. 2009;27:5794–9.
23. Adabag S, Rector TS, Anand IS, JJ MM, Zile M, Komajda M, RS MK,
Massie B, Carson PE. A prediction model for sudden cardiac death in
patients with heart failure and preserved ejection fraction. Eur J Heart
Fail. 2014;16:1175–82.
24. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L,
Chen G, Gharib TG, Thomas DG. Gene-expression profiles predict survival of
patients with lung adenocarcinoma. Nat Med. 2002;8(8):816–24.
25. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG,
Oue N, Yasui W. Relation between microRNA expression and progression
and prognosis of gastric cancer: a microRNA expression analysis. Lancet
Oncol. 2010;11:136–46.
26. Hu X, Schwarz JK, Lewis JS, Huettner PC, Rader JS, Deasy JO, Grigsby PW,
Wang X. A microRNA expression signature for cervical cancer prognosis.
Cancer Res. 2010;70:1441–8.27. Roessler S, et al. A unique metastasis gene signature enables prediction of
tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res.
2010;70:10202–12.
28. Tan Q, Thomassen M, Jochumsen K, Mogensen O, Christensen K, Kruse T.
Gene selection for predicting survival outcomes of cancer patients in
microarray studies. In: Sobh T, editor. Advances in Computer and
Information Sciences and Engineering. Dordrecht: Springer; 2008.
https://link.springer.com/chapter/10.1007/978-1-4020-8741-7_73.
29. Yau C, et al. A multigene predictor of metastatic outcome in early stage
hormone receptor-negative and triple-negative breast cancer. Breast Cancer
Res. 2010;12:R85.
30. Chen Y-C, Ke W-C, Chiu H-W. Risk classification of cancer survival using ANN with
gene expression data from multiple laboratories. Comput Biol Med. 2014;48:1–7.
31. Blanco R, Inza I, Merino M, Quiroga J, Larrañaga P. Feature selection in
Bayesian classifiers for the prognosis of survival of cirrhotic patients treated
with TIPS. J Biomed Inform. 2005;38:376–88.
32. Mankoo PK, Shen R, Schultz N, Levine DA, Sander C. Time to recurrence and
survival in serous ovarian tumors predicted from integrated genomic
profiles. PLoS One. 2011;6:e24709.
33. Wu T, Sun W, Yuan S, Chen C-H, Li K-C. A method for analyzing censored
survival phenotype with gene expression data. BMC Bioinform. 2008;9:417.
34. Lee S, Rahnenführer J, Lang M, De Preter K, Mestdagh P, Koster J, Versteeg
R, Stallings RL, Varesio L, Asgharzadeh S. Robust selection of cancer survival
signatures from high-throughput genomic data using two-fold
subsampling. PLoS One. 2014;9:e108818.
35. Ambler G, Seaman S, Omar R. An evaluation of penalised survival methods for
developing prognostic models with rare events. Stat Med. 2012;31:1150–61.
36. Wu TT, Gong H, Clarke EM. A transcriptome analysis by lasso penalized Cox
regression for pancreatic cancer survival. J Bioinforma Comput Biol. 2011;9:63–73.
37. Fan J, Li R. Variable selection for Cox's proportional hazards model and
frailty model. Ann Stat. 2002;30(1):74–99.
38. Johnson BA. On lasso for censored data. Electronic J Stat. 2009;3:485–506.
39. Garcia RI, Ibrahim JG, Zhu H. Variable selection in the cox regression model
with covariates missing at random. Biometrics. 2010;66:97–104.
40. He Z, Tu W, Wang S, Fu H, Yu Z. Simultaneous variable selection for joint
models of longitudinal and survival outcomes. Biometrics. 2014;71:178–87.
41. Sohn I, Kim J, Jung S-H, Park C. Gradient lasso for Cox proportional hazards
model. Bioinformatics. 2009;25:1775–81.
42. Goeman JJ. L1 penalized estimation in the cox proportional hazards model.
Biom J. 2010;52:70–84.
43. Cai T, Huang J, Tian L. Regularized estimation for the accelerated failure
time model. Biometrics. 2009;65:394–404.
44. Zou H, Hastie T. Regularization and variable selection via the elastic net.
J Royal Stat Soc Ser B. 2005;67:301–20.
45. Khan MHR, Shaw JEH. Variable selection for survival data with a class of
adaptive elastic net techniques. Stat Comput. 2016;26:725–41.
46. Fan J, Li R. Variable selection via nonconcave penalized likelihood and its
oracle properties. J Am Stat Assoc. 2001;96:1348–60.
47. Leung KM, Elashoff RM, Afifi AA. Censoring issues in survival analysis. Annu
Rev Public Health. 1997;18:83–104. doi:10.1146/annurev.publhealth.18.1.83.
48. Bandyopadhyay S, et al. Data mining for censored time-to-event data: a
Bayesian network model for predicting cardiovascular risk from electronic
health record data. Data Min Knowl Disc. 2014;29(4):1–37.
49. Spelt L, Nilsson J, Andersson R, Andersson B. Artificial neural networks–a
method for prediction of survival following liver resection for colorectal
cancer metastases. Eur J Surg Oncol. 2013;39:648–54.
50. Dezfouli HN, Bakar MRA. 2012 International Conference on Statistics in
Science, Business, and Engineering (ICSSBE). Langkawi: IEEE; 2012. p. 1–5.
51. Liu Y, Aickelin U, Feyereisl J, Durrant LG. Wavelet feature extraction and
genetic algorithm for biomarker detection in colorectal cancer data.
Knowl-Based Syst. 2013;37:502–14.
52. Neuvirth H, et al. Toward personalized care management of patients at
risk: the diabetes case study 17th ACM SIGKDD. San Diego: ACM; 2011.
p. 395–403.
53. Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests.
Ann Appl Stat. 2008;2:841–60.
54. Hsich E, Gorodeski EZ, Blackstone EH, Ishwaran H, Lauer MS. Identifying
important risk factors for survival in patient with systolic heart failure using
random survival forests. Circ Cardiovasc Qual Outcomes. 2011;4:39–45.
55. Chen X, Ishwaran H. Pathway hunting by random survival forests.
Bioinformatics. 2013;29:99–105.
Attallah et al. BMC Medical Informatics and Decision Making  (2017) 17:115 Page 19 of 1956. Bühlmann P, Yu B. Boosting with the L2 loss. J Am Stat Assoc.
2003;98:324–39. doi:10.1198/016214503000125.
57. Buehlmann P. Boosting for high-dimensional linear models. Ann Stat.
2006;34:559–83.
58. Chen Y, Jia Z, Mercola D, Xie X. A gradient boosting algorithm for survival
analysis via direct optimization of concordance index. Comput Math
Methods Med. 2013;34:873595.
59. Koziol JA, Feng AC, Jia Z, Wang Y, Goodison S, Mc Clelland M, Mercola D.
The wisdom of the commons: ensemble tree classifiers for prostate cancer
prognosis. Bioinformatics. 2009;25:54–60.
60. Attallah O, Ma X. Bayesian neural network approach for determining the risk
of re-intervention after endovascular aortic aneurysm repair. Proc Inst Mech
Eng H. 2014;228:857–66. doi:10.1177/0954411914549980.
61. Karthikesalingam A, Attallah O, Ma X, Bahia SS, Thompson L, Vidal-Diez A,
Choke EC, Bown MJ, Sayers RD, Thompson MM, Holt PJ. An artificial neural
network stratifies the risks of Reintervention and mortality after
endovascular aneurysm repair; a retrospective observational study. PLoS
One. 2015;10:e0129024.
62. Janecek A, Gansterer WN, Demel M, Ecker G. FSDM 90–105. Antwerp: On the
Relationship Between Feature Selection and Classification Accuracy; 2008.
63. Ting KM, Quek RJY. Third IEEE international conference on data mining,
ICDM 2003: IEEE. p. 653–6.
64. Han L. I. e. K. Model selection and model averaging for neural networks
PhD thesis, Carnegie Mellon University Pittsburgh, (1999).
65. Ghatwary T, Karthikesalingam A, Patterson B, Hinchliffe R, Morgan R, Loftus I,
Salem A, Thompson MM, Holt PJ. St George's vascular institute protocol: an
accurate and reproducible methodology to enable comprehensive
characterization of infrarenal abdominal aortic aneurysm morphology in
clinical and research applications. J Endovasc Ther. 2012;19:400–14.
doi:10.1583/11-3731MR.1.
66. Kaplan EL, Meier P. Nonparametric estimation from incomplete
observations. J Am Stat Assoc. 1958;53:457–81.
67. Goel MK, Khanna P, Kishore J. Understanding survival analysis: Kaplan-Meier
estimate. Int J Ayurveda Res. 2010;1(4):274.
68. Kim H-J. Common factor analysis versus principal component analysis:
choice for symptom cluster research. Asian Nurs Res. 2008;2:17–24.
69. Abdi H, Williams LJ. Principal component analysis. Wiley Interdiscip Rev
Comput Stat. 2010;2:433–59.
70. Jolliffe IT. Principal component analysis. 2nd ed: Springer; 2002.
http://www.springer.com/gp/book/9780387954424.
71. Suhr DD. SUGI 30 203–230. Philadelphia: Principal component analysis vs.
exploratory factor analysis; 2005.
72. Cox DR. Regression models and life-tables. J Royal Stat Soc B. 1972;34:187–220.
73. Cheng J, Greiner R. In advances in artificial Intelligence,14th biennial
conference of the Canadian Society for Computational Studies of
intelligence, AI: Springer. p. 141–51.
74. Karegowda AG, Manjunath A, Jayaram M. Comparative study if attribute
selection using gain ratio and correlation based feature selection. Int J Inf
Technol. 2010;2:271–7.
75. Gupta S, Kumar D, Sharma A. Data mining classification techniques applied for
breast cancer diagnosis and prognosis. Indian J Comput Sci Eng. 2011;2:188–95.
76. Dziuban CD, Shirkey EC. When is a correlation matrix appropriate for factor
analysis? Some decision rules. Psychol Bull. 1974;81:358.
77. Tobias S, Carlson JE. Brief report: Bartlett's test of sphericity and chance
findings in factor analysis. Multivar Behav Res. 1969;4:375–7.
78. Varma S, Simon R. Bias in error estimation when using cross-validation for
model selection. BMC Bioinformatics. 2006;7:1.
79. Molinaro AM, Simon R, Pfeiffer RM. Prediction error estimation: a
comparison of resampling methods. Bioinformatics. 2005;21:3301–7.
80. Matsunaga M. How to factor-analyze your data right: do’s, don’ts, and
how-to’s. Int J Psychol Res. 2015;3:97–110.
81. Fabrigar LR, Wegener DT. Exploratory factor analysis. Oxford: Oxford University
Press; 2011.
82. Costello A, Osborne J. Best practices in exploratory factor analysis: four
recommendations for getting the most from your analysis. Pract Assess Res
Eval. 2005; 10. pareonline. net/getvn. asp;10:7–2011.
83. Perry BB. A genetic algorithm for learning Bayesian network adjacency
matrices from data, PhD thesis. Manhattan: Kansas State University; 2003.
84. Friedman N, Geiger D, Goldszmidt M. Bayesian network classifiers. Mach
Learn. 1997;29:131–63.85. Hassan AM. A probabilistic relaxation framework for learning Bayesian network
structures from data master of science thesis. Giza: Cairo University; 2007.
86. Brown L, Greenhalgh R, Powell J, Thompson S. Use of baseline factors to
predict complications and reinterventions after endovascular repair of
abdominal aortic aneurysm. Br J Surg. 2010;97:1207–17.
87. Peppelenbosch N, et al. Diameter of abdominal aortic aneurysm and outcome
of endovascular aneurysm repair: does size matter? A report from EUROSTAR. J
Vasc Surg. 2004;39:288–97.
88. Lo BW, Macdonald RL, Baker A, Levine MA. Clinical outcome prediction in
aneurysmal subarachnoid hemorrhage using bayesian neural networks with
fuzzy logic inferences. Comput Math Methods Med. 2013;2013:1–11.
89. Wyss TR, Dick F, Brown LC, Greenhalgh RM. The influence of thrombus,
calcification, angulation, and tortuosity of attachment sites on the time to
the first graft-related complication after endovascular aneurysm repair.
J Vasc Surg. 2011;54:965–71.
90. Stather PW, Wild JB, Sayers RD, Bown MJ, Choke E. Endovascular aortic
aneurysm repair in patients with hostile neck anatomy. J Endovasc Ther.
2013;20:623–37.
91. Karthikesalingam A, Holt PJ, Vidal-Diez A, Choke EC, Patterson BO, Thompson LJ,
Ghatwary T, Bown MJ, Sayers RD, Thompson MM. Predicting aortic
complications after endovascular aneurysm repair. Br J Surg. 2013;100:1302–11.
doi:10.1002/bjs.9177.
92. Witten IH, Frank E. Data mining: practical machine learning tools and
techniques. 2nd ed: Morgan Kaufman; 2005. http://www.sciencedirect.com/
science/book/9780123748560.
93. Patterson BO, Hinchliffe RJ, Holt PJ, Loftus IM, Thompson MM. Importance
of aortic morphology in planning aortic interventions. J Endovasc Ther.
2010;17:73–7. doi:10.1583/09-2967C.1.
94. Patterson BO, et al. Existing risk prediction methods for elective abdominal
aortic aneurysm repair do not predict short-term outcome following
endovascular repair. J Vasc Surg. 2010;52:25–30. doi:10.1016/j.jvs.2010.01.084.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
